NASDAQ:AQB - Aquabounty Technologies Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Aquabounty Technologies Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $1.77 -0.07 (-3.81 %) (As of 03/30/2020 12:48 PM ET) Add Compare Today's Range$1.68Now: $1.77▼$1.8050-Day Range$1.52MA: $1.87▼$2.3052-Week Range$1.52Now: $1.77▼$4.08Volume57,161 shsAverage Volume152,491 shsMarket Capitalization$56.60 millionP/E RatioN/ADividend YieldN/ABeta1.03 ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email AquaBounty Technologies, Inc., a biotechnology company, develops and markets products to enhance productivity in aquaculture. It offers AquAdvantage Salmon, a genetically modified Atlantic salmon for human consumption. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was founded in 1991 and is headquartered in Maynard, Massachusetts. AquaBounty Technologies, Inc. is a subsidiary of Intrexon Corporation.Read More Industry, Sector and Symbol Stock Exchange NASDAQ Industry Fishing, hunting & trapping Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:AQB Previous Symbol CUSIPN/A CIK1603978 Webhttp://www.aquabounty.com/ Phone978-648-6000Debt Debt-to-Equity Ratio0.20 Current Ratio2.65 Quick Ratio1.92Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$190,000.00 Price / Sales297.89 Cash FlowN/A Price / Cash FlowN/A Book Value$1.10 per share Price / Book1.61Profitability EPS (Most Recent Fiscal Year)($0.66) Net Income$-13,230,000.00 Net Margins-7,510.69% Return on Equity-49.03% Return on Assets-39.78%Miscellaneous Employees39 Outstanding Shares31,990,000Market Cap$56.60 million Next Earnings Date5/7/2020 (Estimated) OptionableNot Optionable Receive AQB News and Ratings via Email Sign-up to receive the latest news and ratings for AQB and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:AQB Rates by TradingView Aquabounty Technologies (NASDAQ:AQB) Frequently Asked Questions How has Aquabounty Technologies' stock been impacted by COVID-19 (Coronavirus)? Aquabounty Technologies' stock was trading at $1.85 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, AQB stock has decreased by 4.4% and is now trading at $1.7693. View which stocks have been mosted impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Aquabounty Technologies? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aquabounty Technologies in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Aquabounty Technologies. When is Aquabounty Technologies' next earnings date? Aquabounty Technologies is scheduled to release its next quarterly earnings announcement on Thursday, May 7th 2020. View our earnings forecast for Aquabounty Technologies. How were Aquabounty Technologies' earnings last quarter? Aquabounty Technologies Inc (NASDAQ:AQB) issued its quarterly earnings data on Tuesday, March, 10th. The company reported ($0.16) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.13) by $0.03. The firm earned $0.05 million during the quarter, compared to analyst estimates of $0.01 million. Aquabounty Technologies had a negative net margin of 7,510.69% and a negative return on equity of 49.03%. View Aquabounty Technologies' earnings history. What price target have analysts set for AQB? 3 equities research analysts have issued 1 year price targets for Aquabounty Technologies' stock. Their forecasts range from $3.50 to $5.00. On average, they anticipate Aquabounty Technologies' share price to reach $4.50 in the next year. This suggests a possible upside of 154.3% from the stock's current price. View analysts' price targets for Aquabounty Technologies. What are Wall Street analysts saying about Aquabounty Technologies stock? Here are some recent quotes from research analysts about Aquabounty Technologies stock: 1. According to Zacks Investment Research, "AquaBounty Technologies, Inc. is a biotechnology company. It focused on enhancing productivity in aquaculture. The company operates primarily in Maynard, Massachusetts and Fortune, Prince Edward Island. AquaBounty Technologies, Inc. is based in Maynard, United States. " (1/14/2020) 2. National Securities analysts commented, " Second Quarter Results. An operating loss of $4.0 million fell below our estimated loss of $2.8 million, driven largely by sequential increases in G&A from $2.0 million in the first quarter to $3.1 million in the second quarter. We believe some of the increases were one time in nature, although we believe our prior OpEx estimates in advance of commercialization were too light. Production Schedule On Track. With AquAdvantage Salmon (AAS) in the Indiana and Rollo Bay grow out facilities, we continue to expect initial harvests by the end of 2020. A one-time harvest of conventional salmon is also expected in the third quarter of 2020. We look for a regular introduction of AAS into the grow out phase which should enable year-round harvest. What Is Next? With production now underway in both facilities, we believe management is focused on securing buyers for the initial harvest and making preliminary estimates on future expansion. The commercial team is being developed, highlighted by the introduction of CCO David Melbourne Jr in the quarter. We believe expansion plans will be formally announced as commercial revenues are realized and will initially be an expansion of the current Indiana facility. Initial AAS Buyer The Next Major Catalyst. We believe a formal announcement of the first buyers of AAS will represent a significant catalyst for the stock. With the first harvest of AAS anticipated in the third quarter of 2020, we expect buyers to commit around the Spring of 2020. We expect investors on the sideline are awaiting this announcement, and thus believe as buyers are secured and visibility of revenue is enhanced that shares will make a meaningful and sustainable movement upward." (8/7/2019) Has Aquabounty Technologies been receiving favorable news coverage? Media stories about AQB stock have trended very positive recently, according to InfoTrie. The research group rates the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Aquabounty Technologies earned a news impact score of 4.0 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutAquabounty Technologies. Are investors shorting Aquabounty Technologies? Aquabounty Technologies saw a increase in short interest in the month of March. As of March 13th, there was short interest totaling 374,300 shares, an increase of 14.2% from the February 27th total of 327,900 shares. Based on an average trading volume of 210,100 shares, the days-to-cover ratio is presently 1.8 days. Approximately 8.5% of the shares of the stock are short sold. View Aquabounty Technologies' Current Options Chain. Who are some of Aquabounty Technologies' key competitors? Some companies that are related to Aquabounty Technologies include TELIX Pharmaceutical (TLX), Evofem Biosciences (EVFM), ICC Labs (ICC), Co-Diagnostics (CODX), Sutro Biopharma (STRO), New Frontier Health (NFH), Galera Therapeutics (GRTX), Personalis (PSNL), Syros Pharmaceuticals (SYRS), Iradimed (IRMD), Stemline Therapeutics (STML), MannKind (MNKD), SeaSpine (SPNE), Autolus Therapeutics (AUTL) and Next Science (NXS). What other stocks do shareholders of Aquabounty Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Aquabounty Technologies investors own include Celldex Therapeutics (CLDX), Intrexon (XON), Aurora Cannabis (ACB), Ocular Therapeutix (OCUL), NovaBay Pharmaceuticals (NBY), Adaptimmune Therapeutics (ADAP), Genocea Biosciences (GNCA), Opko Health (OPK), Rigel Pharmaceuticals (RIGL) and Rockwell Medical (RMTI). Who are Aquabounty Technologies' key executives? Aquabounty Technologies' management team includes the following people: Mr. David A. Frank, CFO & Treasurer (Age 59)Dr. Ronald L. Stotish, Exec. Director & Chief Technology Officer (Age 70)Mr. Alejandro Rojas, Chief Operating Officer of Aquabounty Farms (Age 57)Ms. Sylvia Wulf, CEO, Pres & Exec. Director (Age 61)Mr. Christopher H. Martin, Gen. Counsel & Company Sec. (Age 53) What is Aquabounty Technologies' stock symbol? Aquabounty Technologies trades on the NASDAQ under the ticker symbol "AQB." Who are Aquabounty Technologies' major shareholders? Aquabounty Technologies' stock is owned by a number of institutional and retail investors. Top institutional investors include ARK Investment Management LLC (1.88%), KBC Group NV (0.29%), Ladenburg Thalmann Financial Services Inc. (0.28%), Renaissance Technologies LLC (0.27%) and Winthrop Advisory Group LLC (0.09%). Company insiders that own Aquabounty Technologies stock include David A Frank and Randal J Kirk. View institutional ownership trends for Aquabounty Technologies. Which institutional investors are selling Aquabounty Technologies stock? AQB stock was sold by a variety of institutional investors in the last quarter, including Ladenburg Thalmann Financial Services Inc.. View insider buying and selling activity for Aquabounty Technologies. Which institutional investors are buying Aquabounty Technologies stock? AQB stock was bought by a variety of institutional investors in the last quarter, including KBC Group NV, Renaissance Technologies LLC, ARK Investment Management LLC, and Winthrop Advisory Group LLC. Company insiders that have bought Aquabounty Technologies stock in the last two years include David A Frank, and Randal J Kirk. View insider buying and selling activity for Aquabounty Technologies. How do I buy shares of Aquabounty Technologies? Shares of AQB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Aquabounty Technologies' stock price today? One share of AQB stock can currently be purchased for approximately $1.77. How big of a company is Aquabounty Technologies? Aquabounty Technologies has a market capitalization of $56.60 million and generates $190,000.00 in revenue each year. The company earns $-13,230,000.00 in net income (profit) each year or ($0.66) on an earnings per share basis. Aquabounty Technologies employs 39 workers across the globe. View additional information about Aquabounty Technologies. What is Aquabounty Technologies' official website? The official website for Aquabounty Technologies is http://www.aquabounty.com/. How can I contact Aquabounty Technologies? Aquabounty Technologies' mailing address is 2 MILL & MAIN PLACE SUITE 395, MAYNARD MA, 01754. The company can be reached via phone at 978-648-6000 or via email at [email protected] MarketBeat Community Rating for Aquabounty Technologies (NASDAQ AQB)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 166 (Vote Outperform)Underperform Votes: 179 (Vote Underperform)Total Votes: 345MarketBeat's community ratings are surveys of what our community members think about Aquabounty Technologies and other stocks. Vote "Outperform" if you believe AQB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AQB will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/30/2020 by MarketBeat.com StaffFeatured Article: What is a dead cat bounce?
